EA-3580
EA-3580 is a chemical compound that belongs to the class of substances known as chemical warfare agents. Specifically, EA-3580 is categorized under the group of V-series nerve agents, which are among the most toxic and rapidly acting substances known in chemical warfare. The V-series agents are characterized by their persistent nature, making them a long-lasting threat in contaminated areas.
Overview[edit]
EA-3580, like other nerve agents, operates by inhibiting the normal function of the enzyme acetylcholinesterase. This enzyme is crucial for the nervous system's operation, as it breaks down the neurotransmitter acetylcholine at the synaptic cleft. By inhibiting acetylcholinesterase, EA-3580 causes an accumulation of acetylcholine, leading to continuous stimulation of muscles, glands, and the central nervous system. This overstimulation can result in a range of symptoms, from blurred vision and excessive salivation to convulsions, respiratory failure, and death.
Chemical Properties and Synthesis[edit]
The specific chemical structure and properties of EA-3580 are not widely disclosed in open literature due to its classification as a chemical weapon. However, it is known that V-series agents, in general, are organophosphorus compounds, and their synthesis involves the alkylation of phosphorus-containing precursors with various alkyl or aryl halides.
Historical Context[edit]
The development of V-series nerve agents, including EA-3580, began in the early 20th century, with significant advancements during and after World War II. These agents were designed to surpass the efficacy and stability of earlier nerve agents, such as those from the G-series, including sarin (GB) and soman (GD). The exact history and deployment of EA-3580 remain classified, but the existence of such compounds underscores the ongoing research and potential proliferation of chemical warfare agents during the Cold War era and beyond.
Health Effects and Treatment[edit]
Exposure to EA-3580, even in small amounts, can be fatal. The symptoms of exposure can appear within seconds to minutes after inhalation and slightly longer after exposure through skin contact. Initial symptoms include runny nose, chest tightness, pinpoint pupils, and excessive sweating. Without immediate treatment, these symptoms can escalate to severe breathing difficulties, convulsions, and ultimately, death due to respiratory failure.
Treatment for EA-3580 exposure includes the immediate administration of antidotes, such as atropine and pralidoxime (2-PAM), which can mitigate the effects of the agent. Removal and decontamination of the contaminated clothing and skin are also critical steps in the treatment process.
Legal Status[edit]
As a chemical warfare agent, the production, stockpiling, and use of EA-3580 are prohibited under the Chemical Weapons Convention (CWC), an international treaty that aims to eliminate chemical weapons and prevent their use. The Organization for the Prohibition of Chemical Weapons (OPCW) oversees the implementation of the CWC and works towards the destruction of existing chemical weapon stockpiles and the prevention of new ones.
Conclusion[edit]
EA-3580 represents a significant threat in the realm of chemical warfare, highlighting the importance of international efforts to control and eliminate such weapons. The persistent nature and high toxicity of V-series nerve agents underscore the necessity of continued vigilance and preparedness in the face of potential chemical threats.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
